Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
New York Mortgage Trust Inc is a reit-mortgage business based in the US. New York Mortgage Trust shares (NYMT) are listed on the NASDAQ and all prices are listed in US Dollars. New York Mortgage Trust employs 63 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$4.42|
|52-week range||$2.26 - $4.72|
|50-day moving average||$4.33|
|200-day moving average||$4.44|
|Wall St. target price||$4.81|
|Dividend yield||$0.375 (8.64%)|
|Earnings per share (TTM)||$0.65|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||1.84%|
|1 month (2021-09-21)||1.84%|
|3 months (2021-07-21)||-1.34%|
|6 months (2021-04-21)||-0.45%|
|1 year (2020-10-21)||70.99%|
|2 years (2019-10-21)||-28.71%|
|3 years (2018-10-19)||5.95|
|5 years (2016-10-21)||6.03|
Valuing New York Mortgage Trust stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of New York Mortgage Trust's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
New York Mortgage Trust's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, New York Mortgage Trust shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
New York Mortgage Trust's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.97. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into New York Mortgage Trust's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$353.9 million|
|Operating margin TTM||80.52%|
|Gross profit TTM||$-218,058,000|
|Return on assets TTM||6.08%|
|Return on equity TTM||12.73%|
|Market capitalisation||$1.6 billion|
TTM: trailing 12 months
There are currently 7.1 million New York Mortgage Trust shares held short by investors – that's known as New York Mortgage Trust's "short interest". This figure is 14.5% down from 8.3 million last month.
There are a few different ways that this level of interest in shorting New York Mortgage Trust shares can be evaluated.
New York Mortgage Trust's "short interest ratio" (SIR) is the quantity of New York Mortgage Trust shares currently shorted divided by the average quantity of New York Mortgage Trust shares traded daily (recently around 2.4 million). New York Mortgage Trust's SIR currently stands at 2.96. In other words for every 100,000 New York Mortgage Trust shares traded daily on the market, roughly 2960 shares are currently held short.
However New York Mortgage Trust's short interest can also be evaluated against the total number of New York Mortgage Trust shares, or, against the total number of tradable New York Mortgage Trust shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case New York Mortgage Trust's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 New York Mortgage Trust shares in existence, roughly 20 shares are currently held short) or 0.0188% of the tradable shares (for every 100,000 tradable New York Mortgage Trust shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against New York Mortgage Trust.
Find out more about how you can short New York Mortgage Trust stock.
Dividend payout ratio: 63.49% of net profits
Recently New York Mortgage Trust has paid out, on average, around 63.49% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 9.24% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), New York Mortgage Trust shareholders could enjoy a 9.24% return on their shares, in the form of dividend payments. In New York Mortgage Trust's case, that would currently equate to about $0.375 per share.
New York Mortgage Trust's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
New York Mortgage Trust's most recent dividend payout was on 24 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 21 September 2021 (the "ex-dividend date").
New York Mortgage Trust's shares were split on a 1:2 basis on 28 May 2008. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your New York Mortgage Trust shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for New York Mortgage Trust shares which in turn could have impacted New York Mortgage Trust's share price.
Over the last 12 months, New York Mortgage Trust's shares have ranged in value from as little as $2.2579 up to $4.7185. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while New York Mortgage Trust's is 1.9243. This would suggest that New York Mortgage Trust's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
New York Mortgage Trust, Inc. acquires, invests in, finances, and manages mortgage-related single-family and multi-family residential assets in the United States. Its targeted investments include residential loans, second mortgages, and business purpose loans; structured multi-family property investments, such as preferred equity in, and mezzanine loans to owners of multi-family properties, as well as joint venture equity investments in multi-family properties; non-agency residential mortgage-backed securities (RMBS); agency RMBS; commercial mortgage-backed securities (CMBS); and other mortgage, residential housing, and credit-related assets. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2003 and is headquartered in New York, New York. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.